 |
PDBsum entry 6tmc
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Antibiotic
|
 |
|
Title:
|
 |
Vim-2_1dh-triazole inhibitors with promising inhibitor effects against antibiotic resistance metallo-beta-lactamases
|
|
Structure:
|
 |
Beta-lactamase class b vim-2. Chain: a. Synonym: blavim-2,class b carbapenemase vim-2,metallo beta-lactamase, metallo-beta lactamase protein,metallo-beta-lactamase vim-2,vim-2, vim-2 beta-lactamase,vim-2 class b metallo b-lactamase,vim-2 type metallo-beta-lactamase. Engineered: yes
|
|
Source:
|
 |
Pseudomonas aeruginosa. Organism_taxid: 287. Gene: blavim-2, bla vim-2, bla-vim-2, blasvim-2, blavim2, blm, vim- 2, vim-2, paerug_p32_london_17_vim_2_10_11_06255. Expressed in: escherichia coli. Expression_system_taxid: 562
|
|
Resolution:
|
 |
|
1.40Å
|
R-factor:
|
0.158
|
R-free:
|
0.168
|
|
|
Authors:
|
 |
H.-K.S.Leiros,T.Christopeit
|
|
Key ref:
|
 |
Z.Muhammad
et al.
(2020).
Structural studies of triazole inhibitors with promising inhibitor effects against antibiotic resistance metallo-β-lactamases.
Bioorg Med Chem,
28,
115598.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
04-Dec-19
|
Release date:
|
22-Jul-20
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
Q9K2N0
(Q9K2N0_PSEAI) -
Beta-lactamase from Pseudomonas aeruginosa
|
|
|
|
Seq: Struc:
|
 |
 |
 |
266 a.a.
231 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Bioorg Med Chem
28:115598
(2020)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structural studies of triazole inhibitors with promising inhibitor effects against antibiotic resistance metallo-β-lactamases.
|
|
Z.Muhammad,
S.Skagseth,
M.Boomgaren,
S.Akhter,
C.Fröhlich,
A.Ismael,
T.Christopeit,
A.Bayer,
H.S.Leiros.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Metallo-β-lactamases (MBLs) are an emerging cause of bacterial antibiotic
resistance by hydrolysing all classes of β-lactams except monobactams, and the
MBLs are not inhibited by clinically available serine-β-lactamase inhibitors.
Two of the most commonly encountered MBLs in clinical isolates worldwide - the
New Delhi metallo-β-lactamase (NDM-1) and the Verona integron-encoded
metallo-β-lactamase (VIM-2) - are included in this study. A series of several
NH-1,2,3-triazoles was prepared by a three-step protocol utilizing Banert
cascade reaction as the key step. The inhibitor properties were evaluated in
biochemical assays against the MBLs VIM-2, NDM-1 and GIM-1, and VIM-2 showed
IC50 values down to nanomolar range. High-resolution crystal
structures of four inhibitors in complex with VIM-2 revealed hydrogen bonds from
the triazole inhibitors to Arg228 and to the backbone of Ala231 or Asn233, along
with hydrophobic interactions to Trp87, Phe61 and Tyr67. The inhibitors show
reduced MIC in synergy assays with Pseudomonas aeruginosa and Escherichia coli
strains harbouring VIM enzymes. The obtained results will be useful for further
structural guided design of MBL inhibitors.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |